¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.
¼ö¸é º¸Á¶ ¼¼°è ½ÃÀåÀº 2021³â¿¡ ¾à 634¾ï 401¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, 2022-2029³â ¿¹Ãø ±â°£ µ¿¾È 6.00% ÀÌ»óÀÇ °ÇÀüÇÑ ¼ºÀå·üÀ» ±â·ÏÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
¼ö¸é º¸Á¶ ½ÃÀåÀº ¼ö¸é¿¡ ¾î·Á¿òÀ» °Þ´Â »ç¶÷µéÀ» µ½±â À§ÇÑ Á¦Ç° ¹× ¼ºñ½º¸¦ Á¦Á¶ ¹× ÆÇ¸ÅÇÏ´Â »ê¾÷À» ¸»ÇÕ´Ï´Ù. ÀÌ ½ÃÀå¿¡´Â ó¹æÀü ¼ö¸é º¸Á¶, ÀϹÝÀǾàǰ ¼ö¸é º¸Á¶, Çãºê ¹× õ¿¬ ¼ö¸é Ä¡·áÁ¦, ¼ö¸é ÃßÀû ÀåÄ¡, ¼ö¸éÀå¾Ö¿¡ ´ëÇÑ ´Ù¾çÇÑ Ä¡·á¹ýÀ» Á¦°øÇÏ´Â ¼ö¸é Ŭ¸®´Ð µî ´Ù¾çÇÑ Á¾·ùÀÇ Á¦Ç°ÀÌ Æ÷ÇԵ˴ϴÙ. ¼¼°è ¼ö¸é º¸Á¶ ½ÃÀåÀÇ ÁÖ¿ä ÃËÁø¿äÀÎÀº ¼ö¸éÀå¾ÖÀÇ À¯º´·ü Áõ°¡, ³ëÀÎ Àα¸ÀÇ Áõ°¡, ½ºÆ®·¹½º°¡ ¸¹Àº ¶óÀÌÇÁ½ºÅ¸ÀÏÀÔ´Ï´Ù. ¶ÇÇÑ, ±â¼ú ¹ßÀü°ú õ¿¬ ¹× Çãºê ¼ö¸é Ä¡·áÁ¦ÀÇ Ã¤Åà Ȯ´ë´Â 2022³âºÎÅÍ 2029³â±îÁö ¿¹Ãø ±â°£ µ¿¾È ½ÃÀå¿¡ À¯¸®ÇÑ ¼ºÀå ±âȸ¸¦ âÃâÇϰí ÀÖ½À´Ï´Ù.
¹Ì±¹¼ö¸éÇùȸ¿¡ µû¸£¸é 2020³â ¹Ì±¹ ¼ºÀÎÀÇ ¾à 30%°¡ ºÒ¸éÁõÀ» ¾Î°í ÀÖÀ¸¸ç, °í·ÉÈ¿¡ µû¶ó ºÒ¸éÁõ À¯º´·üÀÌ ³ô¾ÆÁú °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ¿Í ÇÔ²² 2019³â Journal of Clinical Sleep Medicine¿¡ °ÔÀçµÈ ¿¬±¸¿¡ µû¸£¸é, ¹Ì±¹ ³» ÇÏÁöºÒ¾ÈÁõÈıº(RLS) À¯º´·üÀº ¾à 6.6%·Î ¼ºÀÎ 15¸í Áß 1¸íÀÌ ¾Î°í ÀÖ´Â °ÍÀ¸·Î ÃßÁ¤µË´Ï´Ù. ¸¶Âù°¡Áö·Î The European Sleep Research Society¿¡ µû¸£¸é, À¯·´¿¡¼´Â Àα¸ÀÇ ¾à 20-30%°¡ ºÒ¸éÁõ¿¡ ½Ã´Þ¸®°í ÀÖÀ¸¸ç, ±× À¯º´·üÀº ¿¬·É¿¡ µû¶ó Áõ°¡ÇÏ´Â °ÍÀ¸·Î º¸°íµÇ°í ÀÖ½À´Ï´Ù. ±×·¯³ª ¼ö¸é º¸Á¶ÀÇ ³ôÀº ºñ¿ëÀ¸·Î ÀÎÇØ 2022-2029³â ¿¹Ãø ±â°£ µ¿¾È ½ÃÀå ¼ºÀåÀ» ÀúÇØÇÏ´Â ¿äÀÎÀ¸·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù.
¼ö¸é º¸Á¶ ¼¼°è ½ÃÀå Á¶»ç¿¡¼ °í·ÁµÈ ÁÖ¿ä Áö¿ªÀº ¾Æ½Ã¾ÆÅÂÆò¾ç, ºÏ¹Ì, À¯·´, Áß³²¹Ì, ±âŸ ¶óƾ¾Æ¸Þ¸®Ä«ÀÔ´Ï´Ù. ºÏ¹Ì´Â ¼ö¸éÀå¾ÖÀÇ ³ôÀº À¯º´·ü·Î ÀÎÇØ °¡Àå Å« ¼ö¸é º¸Á¶ ½ÃÀå Áß ÇϳªÀÔ´Ï´Ù. ÀÌ ½ÃÀåÀ» ÁÖµµÇÏ´Â °ÍÀº ¼¼°è ÃÖ´ë ¼ö¸é º¸Á¶ ½ÃÀåÀÎ ¹Ì±¹ÀÔ´Ï´Ù. ÀÇ·áºñ ÁöÃâ Áõ°¡, ¼ö¸éÀå¾Ö¿¡ ´ëÇÑ ÀÎ½Ä Áõ°¡, õ¿¬ Àç·á¿Í Çãºê¸¦ ÀÌ¿ëÇÑ ¼ö¸é Ä¡·áÁ¦ÀÇ Ã¤Åà Ȯ´ë µîÀÇ ¿äÀÎÀÌ ÀÌ Áö¿ªÀÇ ¼ö¸é º¸Á¶ ½ÃÀåÀÇ ¼ºÀåÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¾Æ½Ã¾ÆÅÂÆò¾çÀº °¡Ã³ºÐ ¼Òµæ Áõ°¡, ¾çÁúÀÇ ¼ö¸éÀÇ Á߿伺¿¡ ´ëÇÑ ÀÎ½Ä Áõ°¡, ´Ù¾çÇÑ Á¾·ùÀÇ ¼ö¸é º¸Á¶ÀÇ °¡¿ë¼º µîÀÇ ¿äÀÎÀ¸·Î ÀÎÇØ ¼ö¸é º¸Á¶ ½ÃÀåÀÌ Å©°Ô ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. Áß±¹, ÀϺ», Àεµ¿Í °°Àº ±¹°¡µéÀº ÀÌ Áö¿ªÀÇ ½ÃÀå ¼ºÀå¿¡ Å« ±â¿©¸¦ ÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
ÀÌ Á¶»çÀÇ ¸ñÀûÀº ÃÖ±Ù ¸î ³â µ¿¾È ´Ù¾çÇÑ ºÎ¹®°ú ±¹°¡ÀÇ ½ÃÀå ±Ô¸ð¸¦ Á¤ÀÇÇϰí ÇâÈÄ ¸î ³â µ¿¾ÈÀÇ °¡Ä¡¸¦ ¿¹ÃøÇÏ´Â °ÍÀÔ´Ï´Ù. ÀÌ º¸°í¼´Â Á¶»ç ´ë»ó ±¹°¡ÀÇ »ê¾÷ÀÇ ÁúÀû, ¾çÀû Ãø¸éÀ» ¸ðµÎ Æ÷ÇÔÇϵµ·Ï ¼³°èµÇ¾ú½À´Ï´Ù.
¶ÇÇÑ ½ÃÀåÀÇ ¹Ì·¡ ¼ºÀåÀ» ±ÔÁ¤ÇÏ´Â ÃËÁø¿äÀΰú °úÁ¦¿Í °°Àº Áß¿äÇÑ Ãø¸é¿¡ ´ëÇÑ ÀÚ¼¼ÇÑ Á¤º¸µµ Á¦°øÇÕ´Ï´Ù. ¶ÇÇÑ, ÁÖ¿ä ±â¾÷ÀÇ °æÀï »óȲ°ú Á¦Ç° Á¦°ø¿¡ ´ëÇÑ »ó¼¼ÇÑ ºÐ¼®°ú ÇÔ²² ÀÌÇØ°ü°èÀÚ°¡ ÅõÀÚÇÒ ¼ö ÀÖ´Â ¹Ì½ÃÀû ½ÃÀå¿¡¼ÀÇ ÀáÀçÀû ±âȸµµ Æ÷ÇÔÇÕ´Ï´Ù.
¸ñÂ÷
Á¦1Àå ÁÖ¿ä ¿ä¾à
- ½ÃÀå ÇöȲ
- ¼¼°è¡¤ºÎ¹®º° ½ÃÀå ÃßÁ¤°ú ¿¹Ãø, 2019-2029³â
- ¼ö¸é º¸Á¶ ½ÃÀå, Áö¿ªº°, 2019-2029³â
- ¼ö¸é º¸Á¶ ½ÃÀå, Á¦Ç°º°, 2019-2029³â
- ¼ö¸é º¸Á¶ ½ÃÀå, ¼ö¸éÀå¾Öº°, 2019-2029³â
- ÁÖ¿ä µ¿Çâ
- ÃßÁ¤ ¹æ¹ý
- Á¶»ç °¡Á¤
Á¦2Àå ¼ö¸é º¸Á¶ ¼¼°è ½ÃÀå Á¤ÀÇ¿Í ¹üÀ§
- Á¶»ç ¸ñÀû
- ½ÃÀå Á¤ÀÇ¿Í ¹üÀ§
- Á¶»ç ´ë»ó ¿¬µµ
- ÅëÈ È¯»êÀ²
Á¦3Àå ¼ö¸é º¸Á¶ ¼¼°è ½ÃÀå ¿ªÇÐ
- ¼ö¸é º¸Á¶ ½ÃÀå ¿µÇ⠺м®(2019-2029³â)
- ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
- ¼ö¸éÀå¾Ö À¯º´·ü Áõ°¡
- ³ë³â Àα¸ Áõ°¡
- ½ºÆ®·¹½º ¸¹Àº »ýȰ½À°ü
- ½ÃÀå °úÁ¦
- ½ÃÀå ±âȸ
- ±â¼úÀû Áøº¸ »ó½Â
- õ¿¬ ¼ÒÀ糪 Çãºê¸¦ »ç¿ëÇÑ ¼ö¸éÁ¦ ä¿ë È®´ë
Á¦4Àå ¼ö¸é º¸Á¶ ¼¼°è ½ÃÀå »ê¾÷ ºÐ¼®
- Porter's 5 Force ¸ðµ¨
- °ø±Þ ±â¾÷ÀÇ ±³¼··Â
- ±¸¸ÅÀÚÀÇ ±³¼··Â
- ½Å±Ô Âü¿©¾÷üÀÇ À§Çù
- ´ëüǰÀÇ À§Çù
- °æÀï ±â¾÷°£ °æÀï °ü°è
- Porter's 5 Force ¸ðµ¨ÀÇ ¹Ì·¡ÁöÇâÀû Á¢±Ù¹ý(2019-2029³â)
- PEST ºÐ¼®
- Á¤Ä¡Àû
- °æÁ¦Àû
- »çȸÀû
- ±â¼úÀû
- ÅõÀÚ Ã¤¿ë ¸ðµ¨
- ¾Ö³Î¸®½ºÆ®ÀÇ °á·Ð°ú Á¦¾È
- ž Ŭ·¡½º ÅõÀÚ ±âȸ
- ÁÖ¿ä ¼º°ø Àü·«
Á¦5Àå À§Çè Æò°¡ : COVID-19ÀÇ ¿µÇâ
- COVID-19°¡ ¾÷°è¿¡ ¹ÌÄ¡´Â ÀüüÀûÀÎ ¿µÇâ¿¡ ´ëÇÑ Æò°¡
- COVID-19 ÀÌÀü°ú COVID-19 ÀÌÈÄ ½ÃÀå ½Ã³ª¸®¿À
Á¦6Àå ¼ö¸é º¸Á¶ ¼¼°è ½ÃÀå : Á¦Ç°º°
- ½ÃÀå ÇöȲ
- ¼ö¸é º¸Á¶ ¼¼°è ½ÃÀå, Á¦Ç°º°, ½ÇÀû - ÀáÀ缺 ºÐ¼®
- ¼ö¸é º¸Á¶ ¼¼°è ½ÃÀå, Á¦Ç°º° ÃßÁ¤¡¤¿¹Ãø 2019-2029³â
- ¼ö¸é º¸Á¶ ½ÃÀå, ÇÏÀ§ ºÎ¹®º° ºÐ¼®
- ¸ÅÆ®¸®½º ¹× º£°³
- ¼ö¸é ¿¬±¸¼Ò
- ¾àÁ¦
- ¼ö¸é¹«È£ÈíÁõ¿ë µð¹ÙÀ̽º
Á¦7Àå ¼ö¸é º¸Á¶ ¼¼°è ½ÃÀå : ¼ö¸éÀå¾Öº°
- ½ÃÀå ÇöȲ
- ¼ö¸é º¸Á¶ ¼¼°è ½ÃÀå : ¼ö¸éÀå¾Öº°, ½ÇÀû - ÀáÀ缺 ºÐ¼®
- ¼ö¸é º¸Á¶ ¼¼°è ½ÃÀå, ¼ö¸éÀå¾Öº° ÃßÁ¤¡¤¿¹Ãø 2019-2029
- ¼ö¸é º¸Á¶ ½ÃÀå, ÇÏÀ§ ºÎ¹®º° ºÐ¼®
- ºÒ¸éÁõ
- ¼ö¸é¹«È£ÈíÁõ
- ÇÏÁöºÒ¾ÈÁõÈıº
- ±â¸éÁõ
- ¸ùÀ¯º´
- ±âŸ ¼ö¸éÀå¾Ö
Á¦8Àå ¼ö¸é º¸Á¶ ¼¼°è ½ÃÀå : Áö¿ªº° ºÐ¼®
- ¼ö¸é º¸Á¶ ½ÃÀå, Áö¿ªº° ½ÃÀå ÇöȲ
- ºÏ¹Ì
- ¹Ì±¹
- Á¦Ç°º° ÃßÁ¤¡¤¿¹Ãø, 2019-2029³â
- ¼ö¸éÀå¾Öº° ÃßÁ¤¡¤¿¹Ãø, 2019-2029³â
- ij³ª´Ù
- À¯·´ ¼ö¸é º¸Á¶ ½ÃÀå ÇöȲ
- ¿µ±¹
- µ¶ÀÏ
- ÇÁ¶û½º
- ½ºÆäÀÎ
- ÀÌÅ»¸®¾Æ
- ±âŸ À¯·´
- ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ¼ö¸é º¸Á¶ ½ÃÀå ÇöȲ
- Áß±¹
- Àεµ
- ÀϺ»
- È£ÁÖ
- Çѱ¹
- ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
- ¶óƾ¾Æ¸Þ¸®Ä«ÀÇ ¼ö¸é º¸Á¶ ½ÃÀå ÇöȲ
- ¼¼°è ±âŸ Áö¿ª
Á¦9Àå °æÀï Á¤º¸
- ÁÖ¿ä ½ÃÀå Àü·«
- ±â¾÷ °³¿ä
- Cadwell Industries, Inc.
- ÁÖ¿ä Á¤º¸
- °³¿ä
- À繫(µ¥ÀÌÅÍ ÀÔ¼ö°¡ °¡´ÉÇÑ °æ¿ì¿¡ ÇÑÇÔ)
- Á¦Ç° °³¿ä
- ÃÖ±ÙÀÇ µ¿Çâ
- Compumedics Limited
- Drive DeVilbiss Healthcare Inc.
- GlaxoSmithKline Plc
- Merck& Co., Inc.
- Natus Medical Inc.
- Koninklijke Philips N.V.
- PFIZER, INC.
- Sanofi S.A.
- SleepMed Inc.
Á¦10Àå Á¶»ç °úÁ¤
- Á¶»ç °úÁ¤
- µ¥ÀÌÅÍ ¸¶ÀÌ´×
- ºÐ¼®
- ½ÃÀå ÃßÁ¤
- ½ÂÀÎ
- ÃâÆÇ
- Á¶»ç Ư¡
- Á¶»ç °¡Á¤
ksm 23.06.07
Global Sleep Aids Market is valued approximately USD 63404.01 million in 2021 and is anticipated to grow with a healthy growth rate of more than 6.00% over the forecast period 2022-2029. The sleep aids market refers to the industry that produces and sells products and services that are designed to help people who have trouble sleeping. This market includes various types of products such as prescription sleep aids, over-the-counter sleep aids, herbal and natural sleep remedies, sleep-tracking devices, and sleep clinics that offer various treatments for sleep disorders. The major driving factors for Global Sleep Aids Market is increasing prevalence of sleep disorders, growing geriatric population and stressful lifestyles. Moreover, technological advancements and growing adoption of natural and herbal sleep remedies is creating lucrative growth opportunity for the market over the forecast period 2022-2029.
According to the American Sleep Association, in 2020, insomnia affects about 30% of adults in the United States, and the prevalence of insomnia is expected to rise with the aging population. Along with this, a study published in the Journal of Clinical Sleep Medicine in 2019 found that the prevalence of restless legs syndrome (RLS) in the United States is about 6.6%, affecting an estimated 1 in 15 adults. Similarly, The European Sleep Research Society reports that approximately 20-30% of the population in Europe suffers from insomnia, with the prevalence increasing with age. However, the high cost of Sleep Aids stifles market growth throughout the forecast period of 2022-2029.
The key regions considered for the Global Sleep Aids Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America is one of the largest markets for sleep aids due to the high prevalence of sleep disorders in the region. The market is driven by the United States, which is the largest market for sleep aids in the world. Factors such as rising healthcare expenditure, increasing awareness about sleep disorders, and growing adoption of natural and herbal sleep remedies are driving the growth of the sleep aids market in this region. The Asia-Pacific region is expected to witness significant growth in the sleep aids market due to factors such as increasing disposable income, growing awareness about the importance of good sleep, and the availability of a wide range of sleep aids in the region. Countries such as China, Japan, and India are expected to be major contributors to the growth of the market in the region.
Major market players included in this report are:
- Cadwell Industries, Inc.
- Compumedics Limited
- Drive DeVilbiss Healthcare Inc.
- GlaxoSmithKline Plc
- Merck& Co., Inc.
- Natus Medical Inc.
- Koninklijke Philips N.V.
- PFIZER, INC.
- Sanofi S.A.
- SleepMed Inc.
Recent Developments in the Market:
- In 2020, Philips launched a new line of SmartSleep products designed to improve sleep quality, including a sleep headband and a sleep lamp. The products use advanced technology such as EEG sensors and light therapy to improve sleep quality.
- In 2020, ResMed launched a new portable CPAP device called AirMini, which is designed to help people with sleep apnea sleep better while traveling. The device uses advanced technology such as auto-adjusting pressure and humidification to optimize therapy on-the-go.
Global Sleep Aids Market Report Scope:
- Historical Data: 2019-2020-2021
- Base Year for Estimation: 2021
- Forecast period: 2022-2029
- Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
- Segments Covered: Product, Sleep Disorders, Region
- Regional Scope: North America; Europe; Asia Pacific; Latin America; Rest of the World
- Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below.
By Product:
- Mattress & Pillows
- Sleep Laboratories
- Medications
- Sleep Apnea Devices
By Sleep Disorders:
- Insomnia
- Sleep Apnea
- Restless Leg Syndrome
- Narcolepsy
- Sleepwalking
- Other Sleep Disorders
By Region:
- North America
- U.S.
- Canada
- Europe
- UK
- Germany
- France
- Spain
- Italy
- ROE
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- RoAPAC
- Latin America
- Brazil
- Mexico
- Rest of the World
Table of Contents
Chapter 1. Executive Summary
- 1.1. Market Snapshot
- 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Million)
- 1.2.1. Sleep Aids Market, by Region, 2019-2029 (USD Million)
- 1.2.2. Sleep Aids Market, by Product, 2019-2029 (USD Million)
- 1.2.3. Sleep Aids Market, by Sleep Disorders, 2019-2029 (USD Million)
- 1.3. Key Trends
- 1.4. Estimation Methodology
- 1.5. Research Assumption
Chapter 2. Global Sleep Aids Market Definition and Scope
- 2.1. Objective of the Study
- 2.2. Market Definition & Scope
- 2.2.1. Scope of the Study
- 2.2.2. Industry Evolution
- 2.3. Years Considered for the Study
- 2.4. Currency Conversion Rates
Chapter 3. Global Sleep Aids Market Dynamics
- 3.1. Sleep Aids Market Impact Analysis (2019-2029)
- 3.1.1. Market Drivers
- 3.1.1.1. Increasing prevalence of sleep disorders
- 3.1.1.2. Growing Geriatric Population
- 3.1.1.3. Stressful lifestyles
- 3.1.2. Market Challenges
- 3.1.2.1. High cost of Sleep Aids
- 3.1.3. Market Opportunities
- 3.1.3.1. Rising technological advancements
- 3.1.3.2. Growing adoption of natural and herbal sleep remedies
Chapter 4. Global Sleep Aids Market Industry Analysis
- 4.1. Porter's 5 Force Model
- 4.1.1. Bargaining Power of Suppliers
- 4.1.2. Bargaining Power of Buyers
- 4.1.3. Threat of New Entrants
- 4.1.4. Threat of Substitutes
- 4.1.5. Competitive Rivalry
- 4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
- 4.3. PEST Analysis
- 4.3.1. Political
- 4.3.2. Economical
- 4.3.3. Social
- 4.3.4. Technological
- 4.4. Investment Adoption Model
- 4.5. Analyst Recommendation & Conclusion
- 4.6. Top investment opportunity
- 4.7. Top winning strategies
Chapter 5. Risk Assessment: COVID-19 Impact
- 5.1. Assessment of the overall impact of COVID-19 on the industry
- 5.2. Pre COVID-19 and post COVID-19 Market scenario
Chapter 6. Global Sleep Aids Market, by Product
- 6.1. Market Snapshot
- 6.2. Global Sleep Aids Market by Product, Performance - Potential Analysis
- 6.3. Global Sleep Aids Market Estimates & Forecasts by Product 2019-2029 (USD Million)
- 6.4. Sleep Aids Market, Sub Segment Analysis
- 6.4.1. Mattress & Pillows
- 6.4.2. Sleep Laboratories
- 6.4.3. Medications
- 6.4.4. Sleep Apnea Devices
Chapter 7. Global Sleep Aids Market, by Sleep Disorders
- 7.1. Market Snapshot
- 7.2. Global Sleep Aids Market by Sleep Disorders, Performance - Potential Analysis
- 7.3. Global Sleep Aids Market Estimates & Forecasts by Sleep Disorders 2019-2029 (USD Million)
- 7.4. Sleep Aids Market, Sub Segment Analysis
- 7.4.1. Insomnia
- 7.4.2. Sleep Apnea
- 7.4.3. Restless Leg Syndrome
- 7.4.4. Narcolepsy
- 7.4.5. Sleepwalking
- 7.4.6. Other Sleep Disorders
Chapter 8. Global Sleep Aids Market, Regional Analysis
- 8.1. Sleep Aids Market, Regional Market Snapshot
- 8.2. North America Sleep Aids Market
- 8.2.1. U.S. Sleep Aids Market
- 8.2.1.1. Product breakdown estimates & forecasts, 2019-2029
- 8.2.1.2. Sleep Disorders breakdown estimates & forecasts, 2019-2029
- 8.2.2. Canada Sleep Aids Market
- 8.3. Europe Sleep Aids Market Snapshot
- 8.3.1. U.K. Sleep Aids Market
- 8.3.2. Germany Sleep Aids Market
- 8.3.3. France Sleep Aids Market
- 8.3.4. Spain Sleep Aids Market
- 8.3.5. Italy Sleep Aids Market
- 8.3.6. Rest of Europe Sleep Aids Market
- 8.4. Asia-Pacific Sleep Aids Market Snapshot
- 8.4.1. China Sleep Aids Market
- 8.4.2. India Sleep Aids Market
- 8.4.3. Japan Sleep Aids Market
- 8.4.4. Australia Sleep Aids Market
- 8.4.5. South Korea Sleep Aids Market
- 8.4.6. Rest of Asia Pacific Sleep Aids Market
- 8.5. Latin America Sleep Aids Market Snapshot
- 8.5.1. Brazil Sleep Aids Market
- 8.5.2. Mexico Sleep Aids Market
- 8.6. Rest of The World Sleep Aids Market
Chapter 9. Competitive Intelligence
- 9.1. Top Market Strategies
- 9.2. Company Profiles
- 9.2.1. Cadwell Industries, Inc.
- 9.2.1.1. Key Information
- 9.2.1.2. Overview
- 9.2.1.3. Financial (Subject to Data Availability)
- 9.2.1.4. Product Summary
- 9.2.1.5. Recent Developments
- 9.2.2. Compumedics Limited
- 9.2.3. Drive DeVilbiss Healthcare Inc.
- 9.2.4. GlaxoSmithKline Plc
- 9.2.5. Merck& Co., Inc.
- 9.2.6. Natus Medical Inc.
- 9.2.7. Koninklijke Philips N.V.
- 9.2.8. PFIZER, INC.
- 9.2.9. Sanofi S.A.
- 9.2.10. SleepMed Inc.
Chapter 10. Research Process
- 10.1. Research Process
- 10.1.1. Data Mining
- 10.1.2. Analysis
- 10.1.3. Market Estimation
- 10.1.4. Validation
- 10.1.5. Publishing
- 10.2. Research Attributes
- 10.3. Research Assumption